Hong Kong will open its yearly International Healthcare Week in May, BioSpectrum Asia reported, built around two trade events that pair investment matching with a show of medical technology. It is anchored by the sixth Asia Summit on Global Health, run jointly by the Government of the Hong Kong Special Administrative Region and the Hong Kong Trade Development Council (HKTDC), and by the seventeenth Hong Kong International Medical and Healthcare Fair, which the HKTDC runs on its own. BioSpectrum Asia framed the week as a bid to hold the city’s place as a health destination and a medical tourism gateway into mainland China and the region.
The Asia Summit on Global Health, or ASGH, has run since 2021. Its 2026 edition carries the theme “Fuelling Healthcare Breakthroughs”, BioSpectrum Asia reported, and will draw senior officials, investors, service providers and researchers across a run of plenary and thematic sessions. Organisers pitched the summit as a place where health firms and foreign money meet, not as a clinical event.
What the summit puts on the floor
The ASGH programme runs to five themes. BioSpectrum Asia listed the next stage of China’s health industry, advances in traditional Chinese medicine, silver health and smart ageing, medical AI and robotics, and gene and cell therapies. More than 170 exhibitors and start-ups will show in a set-aside zone, the report said, next to the ASGH Business Hub for health institutions and an InnoHealth Showcase that puts global investors in front of young firms. A separate deal-making track offers project owners face-to-face time with backers.
Traditional Chinese medicine sits on that list for a reason. It is the same draw that other Chinese cities are building their medical tourism pitch around, from Guangzhou’s international service centre to the wider national bet on traditional Chinese medicine as a health export. The AI and robotics strand tracks Hong Kong’s own push into robotic surgery, a skill the city has already sold to foreign patients.
The fair and its numbers
The Medical Fair runs at the same time, with about 300 exhibitors from 10 countries and regions under the theme “Innovations Boosting Smart Health Experience”, BioSpectrum Asia reported. Its zones cover start-ups, hospital kit and digital health, biotech and laboratory diagnostics, rehab and elderly care, medical supplies, and health and wellness. This year it weights three areas the report labelled “MedTech”, “GeronTech” and preventive healthcare. More than 50 seminars and forums run beside it.
Those figures set the scale of the event, not any medical tourism outcome. In 2025 the fair drew more than 14,000 buyers from 57 countries and regions and held more than 660 business matching meetings, BioSpectrum Asia reported. They are trade-show counts, supplied by the Hong Kong Trade Development Council. They track traffic through a hall, not foreign patients treated in a hospital.
Reading the announcement
There is a standing way to read an event like this. A trade week is an announcement, and an announcement is not a capacity figure. Buyer counts, booth totals and meeting tallies measure the interest a place can pull in. They do not measure the beds, the units or the foreign patients that a medical tourism destination treats. Hong Kong is holding the summit and the fair on the strength of its money and research base, and the themes it picked, ageing, traditional Chinese medicine and robotics, track where demand is moving. Whether that pulling power turns into treated patients is a separate question the week cannot settle.
The gap matters because trade-show scale is easy to grow and hospital throughput is not. A city can add exhibitors in a year by selling more booths. It cannot add beds or foreign patient volume on the same clock, and medical tourism turns on the second number, not the first. The summit convenes the money and the technology; the shift into patient care runs slower.
The test is dated and countable. In 2025 the fair reported more than 14,000 buyers and more than 660 matching meetings, and the 2026 edition will show whether they hold or rise once the week opens in May. The number worth watching sits a step down, at the hospitals. It is how many foreign patients Hong Kong’s accredited sites report treating in the year after the week, set against the traditional Chinese medicine and robotic-surgery skills the summit spent its sessions selling.
